Sign in to view content

Efficacy and Safety of Biosimilar Ranibizumab-nuna and Ranibizumab-eqrn in Clnical Use by a Consortium of Retina Specialists

Carl C. Awh, MD, FASRS

Video
Published 2023

Related

Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results
Peter J. Kertes, MD, FRCS(C)
Annual Meeting Talks
2020
Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2019
Comparison of Originator and Biosimilar Medications for Pediatric Noninfectious Uveitis
Nita Valikodath, MD, MS
Annual Meeting Talks
2023

Category: Pharmacology

See more